UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SQNM
951
DELISTED
SEQUENOM INC NEW
SQNM
| $6.49M | 0.01% |
1,641,796
+2,500
| +0.2% | +$9.18K |
|
952
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $6.47M | 0.01% |
162,534
-317,514
| -66% | -$12.4M |
|
|
X
953
DELISTED
US Steel
X
| $6.47M | 0.01% |
265,125
+11,584
| +5% | +$275K |
|
954
Brixmor Property Group
BRX
$9.32B
| $6.47M | 0.01% |
243,646
+44,314
| +22% | +$1.16M |
|
955
Atara Biotherapeutics
ATRA
$76.1M
| $6.41M | 0.01% |
6,165
+3,873
| +169% | +$2.56M |
|
|
ACHN
956
DELISTED
Achillion Pharmaceuticals
ACHN
| $6.29M | 0.01% |
638,459
+10,200
| +2% | +$127K |
|
957
RLJ Lodging Trust
RLJ
$1.69B
| $6.27M | 0.01% |
200,273
+8,900
| +5% | +$294K |
|
958
Saia
SAIA
$9.72B
| $6.26M | 0.01% |
141,298
-71,900
| -34% | -$3.31M |
|
|
RPAI
959
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $6.23M | 0.01% |
388,772
-4,257
| -1% | -$71.3K |
|
|
FCE.A
960
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $6.23M | 0.01% |
244,212
+5,015
| +2% | +$123K |
|
961
Fortune Brands Innovations
FBIN
$6.06B
| $6.19M | 0.01% |
152,546
-2,508
| -2% | -$97.6K |
|
962
Reinsurance Group of America
RGA
$16.1B
| $6.19M | 0.01% |
66,410
+1,500
| +2% | +$132K |
|
963
Community Health Systems
CYH
$423M
| $6.14M | 0.01% |
142,021
-282,422
| -67% | -$11.7M |
|
964
Banco Santander Chile
BSAC
$16.6B
| $6.13M | 0.01% |
282,639
+94,400
| +50% | +$1.91M |
|
965
United Therapeutics
UTHR
$23.1B
| $6.08M | 0.01% |
35,272
+6,385
| +22% | +$973K |
|
966
Essent Group
ESNT
$6.33B
| $6.04M | 0.01% |
252,682
-4,400
| -2% | -$106K |
|
967
Huntington Ingalls Industries
HII
$12.8B
| $5.94M | 0.01% |
42,367
-14,025
| -25% | -$1.81M |
|
968
Wipro
WIT
$20B
| $5.89M | 0.01% |
+2,357,333
| New | +$5.77M |
|
969
Baytex Energy
BTE
$2.92B
| $5.87M | 0.01% |
371,285
+25,052
| +7% | +$398K |
|
|
EQC
970
DELISTED
Equity Commonwealth
EQC
| $5.84M | 0.01% |
220,013
+4,900
| +2% | +$129K |
|
971
Ambev
ABEV
$46.4B
| $5.82M | 0.01% |
1,010,400
+59,600
| +6% | +$370K |
|
|
KEYW
972
DELISTED
The KEYW Holding Corporation
KEYW
| $5.76M | 0.01% |
700,395
-8,000
| -1% | -$70.8K |
|
973
Arthur J. Gallagher & Co
AJG
$63.6B
| $5.76M | 0.01% |
123,269
+6,407
| +5% | +$299K |
|
974
Vail Resorts
MTN
$5.3B
| $5.63M | 0.01% |
54,469
-3,869
| -7% | -$350K |
|
|
BRLI
975
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $5.62M | 0.01% |
159,340
+36,500
| +30% | +$1.23M |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.